Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832588 (
PSS
)
2,979
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The assessment of the soluble immune complexes (IC) in human sera is traditionally performed by the C1q binding assay. In the present study, a novel method for the quantity of immune complexes was reported. The methodology was based on measuring their deposition on solid-phase C3 binding
glycoprotein
(CIF), using an enzyme-linked immunosorbent assay. We also used ELISA that employed anti-C3 antibodies to determined the quantity of immune complexes. The three assays were evaluated for their performance characteristics on the same specially prepared samples: 55 normal sera, 99 sera from RA, 88 sera from SLE, and 27 sera from
PSS
. The results were compared by reference to a common standard-heat aggregated IgG that possesses many activities of immune complexes. Three of the tests used displayed almost the same specificity (over 95%), while their relative sensitivity varied depending on the disease sera tested. The sensitivity of the assays used was recorded highest for C1q ELISA-28.97% of positive sera, followed by CIF-ELISA-19.63% and lowest for anti-C3 ELISA-17.29%. A well-expressed correlation was found between CIF-ELISA and anti-C3 ELISA data (r=0.42), and a week correlation was noted when comparing CIF-ELISA and C1q ELISA IC levels detected (r=0.28). When the correlation coefficients were calculated individually for each disease category, they were clearly different, and that reflected indirectly in different sensitivities of the test for various disease categories. We also found that the results from the simultaneous performance of the tests demonstrated low percentage positive results when three or two assays were used. This is most probably due to the different assay abilities to detect IC with different sizes and composition, which shows that a small part of IC in the tested sera can be detected simultaneously by more than one assay. On the basis of the results obtained, we concluded that optimal screening for IC could be achieved by parallel application of several different methods.
...
PMID:Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA. 1138 65
In this paper, we constructed an interface that not only retains viability of immobilized BGC823 human gastric carcinoma cells (BGC823 cells) but also efficiently resists nonspecific adsorption of the P-glycoprotein antibody and its secondary antibody, which enabled us to sensitively detect the number of cells and P-glycoproteins on the BGC823 cell surface by the immunoassay method. Preparation of the film was quite simple and inexpensive just by spin-coating poly(dimethylsiloxane) (PDMS) doped with poly(diallydimethylammonium) (PDDA) on the surface of gold electrodes. The composite film's biocompatibility, antinonspecific adsorption ability, and the conductivity for electrochemical probe ([Fe(CN)6]3-/4-) were proved by cell culture experiments, blocking experiments, and electrochemical experiments. Compared with PDMS and PDMS doped with poly(sodium 4-styrenesulfonate) (
PSS
), the PDMS-PDDA composite film showed a predominant ability to capture cells due to electrostatic reaction between the presence of positively charged PDDA and the negatively charged glycocalyx on the surface of cells. On the advantage of electrochemical immunoassay with a signal amplification path by using biocatalytic precipitation of an insoluble product, differential pulse voltammetry (DPV) measurement based on the changes of electron-transfer resistance was introduced to detect the cell amount and monitor growing states of cells like adhesion, spread, proliferation, and apoptosis on the electrodes. Optimally, signal response was proportional to the logarithm of cell concentration ranging from 1.0 x 10(3) to 5.0 x 10(7) cells mL(-1) with a detection limit of 7.2 x 10(2) cells mL(-1). On the basis of the special property for resisting nonspecific adsorption of this composite film, an ultraviolet and visible (UV-vis) absorption spectrum with one-step immunoreaction was employed to evaluate the P-glycoprotein on the BGC823 cell surface. The P-glycoprotein on a single living intact BGC823 cell was detected correspondingly to 4.7 x 10(7) molecules. The work implied that the composite film possessed potential applications for biosensing and convenient evaluation of surface
glycoprotein
on living cells.
...
PMID:Cytosensing and evaluation of cell surface glycoprotein based on a biocompatible poly(diallydimethylammonium) doped poly(dimethylsiloxane) film. 1943 75